title: Authors' reply to Bjerrum and colleagues.
authors.affiliation: Aldermoore Health Centre, University of Southampton Medical School, Southampton SO16 5ST, UK.
authors.forename: Paul
authors.initials: P
authors.lastname: Little
authors.forename: Michael
authors.initials: M
authors.lastname: Moore
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D000942:Antigens, Bacterial / Q000097:blood* / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D007159:Immunologic Tests / Q000379:methods*; D008297:Male; D010612:Pharyngitis / Q000188:drug therapy* / Q000382:microbiology*; D010818:Practice Patterns, Physicians'; D011320:Primary Health Care; D013290:Streptococcal Infections / Q000188:drug therapy*; D013297:Streptococcus pyogenes / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial